Michael E. Kort

3.4k citations

36 papers · 1.6k indexed · h-index 22

Impact in

Sensory Systems top 0.5%
- Ion Channels and Receptors
Physiology top 0.5%
- Pain Mechanisms and Treatments
- Adenosine and Purinergic Signaling

Papers in ⓘ

Sensory Systems 14
- Ion Channels and Receptors 14
Biochemistry 4
- Phytochemicals and Antioxidant Activities 4

Co-authors: Philip R. Kym (12 shared papers)Connie R. Faltynek (7 shared papers)Eric A. Voight (5 shared papers)Steve McGaraughty (5 shared papers)Michael F. Jarvis (6 shared papers)Prisca Honoré (7 shared papers)Katharine L. Chu (2 shared papers)Charles W. Hutchins (2 shared papers)
Journals: Journal of Medicinal Chemistry (6 papers)Tetrahedron Letters (3 papers)Current Topics in Medicinal Chemistry (2 papers)Journal of Neuroscience (2 papers)Expert Opinion on Therapeutic Patents (2 papers)
Partner nations: United States United Kingdom Netherlands

In The Last Decade

Michael E. Kort

35 papers receiving 1.6k citations

Peers

Countries citing papers authored by Michael E. Kort

Since Specialization

Citations

This map shows the geographic impact of Michael E. Kort's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Kort with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Kort more than expected).

Fields of papers citing papers by Michael E. Kort

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Kort. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Kort. The network helps show where Michael E. Kort may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael E. Kort, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael E. Kort Line = papers co-authored together Michael E. Kort links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 36 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Structure−Activity Relationship Studies on a Series of Novel, Substituted 1-Benzyl-5-phenyltetrazole P2X₇Antagonists Journal of Medicinal Chemistry ·Derek W. Nelson, Robert J. Gregg, Michael E. Kort, Arturo Perez‐Medrano, Eric A. Voight, Ying Wang, George Grayson, Marian T. Namovic, Diana L. Donnelly‐Roberts, Wende Niforatos, Prisca Honoré, Michael F. Jarvis, Connie R. Faltynek, William A. Carroll	2006	210
2	P2X7-related modulation of pathological nociception in rats Neuroscience ·Steve McGaraughty, K. L. Chu, Marian T. Namovic, Diana L. Donnelly‐Roberts, Richard R. Harris, X.-F. Zhang, C C Shieh, Carol T. Wismer, C.Z. Zhu, Donna M. Gauvin, A. Fabiyi, Prisca Honoré, Robert J. Gregg, Michael E. Kort, Derek W. Nelson, William A. Carroll, Kennan C. Marsh, Connie R. Faltynek, Michael F. Jarvis	2007	194
3	TRPA1 Modulation of Spontaneous and Mechanically Evoked Firing of Spinal Neurons in Uninjured, Osteoarthritic, and Inflamed Rats Molecular Pain ·Steve McGaraughty, Katharine L. Chu, Richard J. Perner, Stan DiDomenico, Michael E. Kort, Philip R. Kym	2010	147
4	Molecular Determinants of Species-Specific Activation or Blockade of TRPA1 Channels Journal of Neuroscience ·Jun Chen, Xufeng Zhang, Michael E. Kort, Jeffrey R. Huth, Chaohong Sun, Laura J. Miesbauer, Steven Cassar, Torben R. Neelands, Victoria Scott, Robert B. Moreland, Regina M. Reilly, Philip J. Hajduk, Philip R. Kym, Charles W. Hutchins, Connie R. Faltynek	2008	95
5	Analgesic potential of TRPV1 antagonists Biochemical Pharmacology ·Philip R. Kym, Michael E. Kort, Charles W. Hutchins	2009	90
6	Nonsteroidal Selective Glucocorticoid Modulators: The Effect of C-10 Substitution on Receptor Selectivity and Functional Potency of 5-Allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines Journal of Medicinal Chemistry ·Philip R. Kym, Michael E. Kort, Michael J. Coghlan, J. L. MOORE, Rui Tang, James D. Ratajczyk, Daniel P. Larson, Steven W. Elmore, John K. Pratt, Michael A. Stashko, H. Douglass Falls, Chun Wel Lin, Masake Nakane, Loan Miller, Curtis M. Tyree, Jeffery N. Miner, Peer B. Jacobson, Denise M. Wilcox, Phong Nguyen, Benjamin C. Lane	2003	86
7	A Selective Nav1.8 Sodium Channel Blocker, A-803467 [5-(4-Chlorophenyl-N-(3,5-dimethoxyphenyl)furan-2-carboxamide], Attenuates Spinal Neuronal Activity in Neuropathic Rats Journal of Pharmacology and Experimental Therapeutics ·Steve McGaraughty, Katharine L. Chu, Marc J. C. Scanio, Michael E. Kort, Connie R. Faltynek, Michael F. Jarvis	2007	69
8	Transient Receptor Potential Channel Ankyrin-1 Is Not a Cold Sensor for Autonomic Thermoregulation in Rodents Journal of Neuroscience ·Cristiane de Oliveira, András Garami, Sonya G. Lehto, Eszter Pákai, Valéria Tékus, Krisztina Pohóczky, Beth D. Youngblood, Weiya Wang, Michael E. Kort, Philip R. Kym, Erika Pintér, Narender R. Gavva, Andrej A. Romanovsky	2014	62
9	Transient receptor potential vanilloid-1 antagonists: a survey of recent patent literature Expert Opinion on Therapeutic Patents ·Eric A. Voight, Michael E. Kort	2010	59
10	A-995662 [(R)-8-(4-methyl-5-(4-(trifluoromethyl)phenyl)oxazol-2-ylamino)-1,2,3,4-tetrahydronaphthalen-2-ol], a novel, selective TRPV1 receptor antagonist, reduces spinal release of glutamate and CGRP in a rat knee joint pain model Pain ·Pamela S. Puttfarcken, Ping Han, Shailen K. Joshi, Torben R. Neelands, Donna M. Gauvin, Scott Baker, La Geisha R. Lewis, Bruce R. Bianchi, Joseph P. Mikusa, John R. Koenig, Richard J. Perner, Michael E. Kort, Prisca Honoré, Connie R. Faltynek, Philip R. Kym, Regina M. Reilly	2010	57
11	TRPV1 Antagonists Progress in medicinal chemistry ·Michael E. Kort, Philip R. Kym	2012	52
12	IL-23 induces regulatory T cell plasticity with implications for inflammatory skin diseases Scientific Reports ·Arun Kannan, Zhi Su, Donna M. Gauvin, Stephanie Paulsboe, Ryan Duggan, Loren Lasko, Prisca Honoré, Michael E. Kort, Steve McGaraughty, Victoria Scott, Stephen B. Gauld	2019	46
13	A-887826 is a structurally novel, potent and voltage-dependent Nav1.8 sodium channel blocker that attenuates neuropathic tactile allodynia in rats Neuropharmacology ·Xu‐Feng Zhang, Char‐Chang Shieh, Mark L. Chapman, Mark A. Matulenko, Ahmed H. Hakeem, Robert N. Atkinson, Michael E. Kort, Brian E. Marron, Shailen K. Joshi, Prisca Honoré, Connie R. Faltynek, Douglas S. Krafte, Michael F. Jarvis	2010	44
14	Additive Antinociceptive Effects of the Selective Nav1.8 Blocker A-803467 and Selective TRPV1 Antagonists in Rat Inflammatory and Neuropathic Pain Models Journal of Pain ·S. K. Joshi, Prisca Honoré, Gricelda Hernandez, Robert G. Schmidt, Arthur Gomtsyan, Marc J. C. Scanio, Michael E. Kort, Michael F. Jarvis	2008	40
15	The Pursuit of Differentiated Ligands for the Glucocorticoid Receptor Current Topics in Medicinal Chemistry ·Michael J. Coghlan, Steven Elmore, Philip R. Kym, Michael E. Kort	2003	37
16	Total synthesis of ionophore antibiotic X-14547 A (indanomycin) The Journal of Organic Chemistry ·Steven D. Burke, Anthony D. Piscopio, Michael E. Kort, Mark A. Matulenko, Marshall H. Parker, David M. Armistead, K. Shankaran	1994	33
17	A Comparison of DNA Cleavage by Neocarzinostatin Chromophore and Its Aglycon: Evaluating the Role of the Carbohydrate Residue Journal of the American Chemical Society ·Andrew G. Myers, Michael E. Kort, Marlys Hammond	1997	32
18	Synthesis and biological evaluation of 5-substituted and 4,5-disubstituted-2-arylamino oxazole TRPV1 antagonists Bioorganic & Medicinal Chemistry ·Richard J. Perner, John R. Koenig, Stanley DiDomenico, Arthur Gomtsyan, Robert G. Schmidt, Chih‐Hung Lee, Margaret C. Hsu, Heath A. McDonald, Donna M. Gauvin, Shailen K. Joshi, Teresa M. Turner, Regina M. Reilly, Philip R. Kym, Michael E. Kort	2010	31
19	Synthesis and Structure−Activity Relationships of a Novel Series of Tricyclic Dihydropyridine-Based K_ATP Openers That Potently Inhibit Bladder Contractions in Vitro Journal of Medicinal Chemistry ·William A. Carroll, Konstantinos A. Agrios, Robert J. Altenbach, Steven A. Buckner, Yiyuan Chen, Michael J. Coghlan, A.V. Daza, Irene Drizin, Murali Gopalakrishnan, Rodger F. Henry, Michael E. Kort, Philip R. Kym, Ivan Milicic, Jamie C. Smith, Rui Tang, Sean Turner, Kristi L. Whiteaker, Henry Zhang, James P. Sullivan	2004	29
20	Enantioselective synthesis of nagilactone F via vinylsilane-terminated cationic cyclization Tetrahedron Letters ·Steven D. Burke, Michael E. Kort, Sharon M. S. Strickland, Helen M. Organ, Louis A. Silks	1994	25

About Michael E. Kort

Michael E. Kort is a scholar working on Sensory Systems, Biochemistry, Physiology, Complementary and alternative medicine and Physiology, having authored 36 papers that have together received 1.6k indexed citations. Recurring topics across this work include Ion Channels and Receptors (14 papers), Pain Mechanisms and Treatments (12 papers), Ion channel regulation and function (7 papers), Herbal Medicine Research Studies (4 papers), Cardiac Ischemia and Reperfusion (4 papers), Phytochemicals and Antioxidant Activities (4 papers), Chemical Synthesis and Analysis (3 papers) and Synthetic Organic Chemistry Methods (3 papers). The work is most often cited by research in Sensory Systems (539 citations), Physiology (324 citations), Cellular and Molecular Neuroscience (332 citations), Biochemistry (108 citations) and Physiology (453 citations). Michael E. Kort has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Philip R. Kym, Connie R. Faltynek, Eric A. Voight, Steve McGaraughty, Michael F. Jarvis, Prisca Honoré, Katharine L. Chu, Charles W. Hutchins, William A. Carroll and Richard J. Perner. Their work appears in journals such as Journal of Medicinal Chemistry, Tetrahedron Letters, Current Topics in Medicinal Chemistry, Journal of Neuroscience and Expert Opinion on Therapeutic Patents.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact